
|Articles|May 15, 2020
ASCRS 2020: TearClear CEO shares company's vision, mission for future
Author(s)Alex Delaney-Gesing
Advertisement
Ophthalmology Times' Sheryl Stevenson speaks with Robert Dempsey, TearClear's new CEO, on his goals for the company, its mission and vision in the future of the coronavirus, as well as what to keep an eye out for at the 2020 ASCRS virtual meeting.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: A new biomechanical paradigm for presbyopia
2
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined
3
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
4
Clinical Experience and Integration of New Dry Eye Disease Therapies in the Clinic
5

















































.png)


